{
"description": "臺灣衛生福利部中央健康保險署「給付適應症」代碼,代碼出版日期:2025-05-05;資料所屬單位:臺灣衛生福利部中央健康保險署。",
"_filename": "CodeSystem-nhi-apply-reason.json",
"package_name": "tw.gov.mohw.nhi.pas",
"date": "2025-05-05",
"publisher": "衛生福利部中央健康保險署",
"content": "complete",
"name": "NHIApplyReason",
"type": null,
"experimental": "false",
"resourceType": "CodeSystem",
"title": "NHI-健保事前審查-給付適應症",
"package_version": "1.0.4",
"status": "active",
"id": "72d3c67d-8bbb-4c61-819f-3319865fcde2",
"kind": null,
"count": 23,
"url": "https://nhicore.nhi.gov.tw/pas/CodeSystem/nhi-apply-reason",
"concept": [ {
"code": "C50P1",
"display": "早期乳癌-未發生腋下淋巴結轉移"
}, {
"code": "C50P2",
"display": "早期乳癌-具腋下淋巴結轉移"
}, {
"code": "C50R1",
"display": "轉移性乳癌"
}, {
"code": "C16R1",
"display": "轉移性胃癌"
}, {
"code": "P001",
"display": "黑色素瘤"
}, {
"code": "P011",
"display": "非小細胞肺癌-SQ-2線"
}, {
"code": "P012",
"display": "非小細胞肺癌-Adeno-3線"
}, {
"code": "P013",
"display": "非小細胞肺癌-1線"
}, {
"code": "P014",
"display": "鱗狀非小細胞肺癌第一線用藥(併用化療)"
}, {
"code": "P021",
"display": "小細胞肺癌(併用化療)"
}, {
"code": "P031",
"display": "典型何杰金氏淋巴瘤"
}, {
"code": "P041",
"display": "泌尿道上皮癌-2線"
}, {
"code": "P042",
"display": "泌尿道上皮癌-1線"
}, {
"code": "P043",
"display": "局部晚期或轉移性泌尿道上皮癌之維持療法"
}, {
"code": "P052",
"display": "胃癌-1線(併用化療)"
}, {
"code": "P061",
"display": "腎細胞癌"
}, {
"code": "P072",
"display": "晚期肝細胞癌-1線(併用標靶bevacizumab)"
}, {
"code": "P081",
"display": "頭頸部鱗狀細胞癌第二線用藥"
}, {
"code": "P082",
"display": "頭頸部鱗狀細胞癌第一線用藥"
}, {
"code": "P091",
"display": "默克細胞癌"
}, {
"code": "P101",
"display": "食道鱗狀細胞癌"
}, {
"code": "P111",
"display": "惡性肋膜間皮瘤(ipilimumab併用nivolumab 120mg)"
}, {
"code": "P121",
"display": "膽道癌(併用化療)"
} ],
"caseSensitive": true,
"version": "1.0.4",
"contact": [ {
"name": "衛生福利部中央健康保險署",
"telecom": [ {
"value": "https://www.nhi.gov.tw",
"system": "url"
} ]
} ]
}